US government, Pfizer and others side with Sanofi and Regeneron in Supreme Court patent case

Pfizer, Viatris, the US government and others on Friday submitted briefs to the Supreme Court backing Sanofi and Regeneron in their fight against Amgen over patents that cover their PCSK9 inhibitors to control cholesterol.